Clinical Trials Browser

Phase 2 × Lymphoma, T-Cell, Peripheral × Bleomycin × Clear all

NCT00136565 2018-08-23

Study of Bortezomib Combined With ACVBP in Peripheral T-cell Lymphoma

Phase 2 Completed

Lymphoma, T-Cell, Peripheral